Evidence map›Paper›PMID 30154568›Full record

ArticleScientific reports2018

Dynamic expression of HOPX in alveolar epithelial cells reflects injury and repair during the progression of pulmonary fibrosis.

Chiharu Ota, John-Poul Ng-Blichfeldt, Martina Korfei, Hani N Alsafadi, Mareike Lehmann, Wioletta Skronska-Wasek, Martina M De Santis, Andreas Guenther, Darcy E Wagner, Melanie Königshoff

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. PPM1A as a key target of the application ofMolecular medicine reports · 2021
    Article
  17. HOPXAmerican journal of physiology. Gastrointestinal and liver physiology · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 5 countries.

Chiharu OtaResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany. chiharu.ota.e8@tohoku.ac.jp.
John-Poul Ng-BlichfeldtDepartment of Molecular Pharmacology, Groningen Research Institute for Asthma and COPD (GRIAC), University of Groningen, Groningen, The Netherlands.
Martina KorfeiDepartment of Pulmonary and Critical Care, Justus-Liebig University School of Medicine, Member of the German Center for Lung Research (DZL), Giessen, Germany.
Hani N AlsafadiResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID 0000-0002-1186-2517
Mareike LehmannResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.
Wioletta Skronska-WasekResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.
Martina M De SantisResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID 0000-0002-0733-2599
Andreas GuentherDepartment of Pulmonary and Critical Care, Justus-Liebig University School of Medicine, Member of the German Center for Lung Research (DZL), Giessen, Germany.
Darcy E WagnerResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.ORCID 0000-0003-3794-1309
Melanie KönigshoffResearch Unit Lung Repair and Regeneration, Helmholtz Zentrum München and University Hospital of the Ludwig Maximilians Universität, Member of the German Center for Lung Research (DZL), Munich, Germany.
Helmholtz Zentrum München · DEGerman Center for Lung Research · DELund University · SETohoku University · JPUniversity of Groningen · NL

Funding

European Research Council 261302
6 · The paper itself

Abstract

Mechanisms of injury and repair in alveolar epithelial cells (AECs) are critically involved in the progression of various lung diseases including idiopathic pulmonary fibrosis (IPF). Homeobox only protein x (HOPX) contributes to the formation of distal lung during development. In adult lung, alveolar epithelial type (AT) I cells express HOPX and lineage-labeled Hopx+ cells give rise to both ATI and ATII cells after pneumonectomy. However, the cell function of HOPX-expressing cells in adult fibrotic lung diseases has not been investigated. In this study, we have established a flow cytometry-based method to evaluate HOPX-expressing cells in the lung. HOPX expression in cultured ATII cells increased over culture time, which was accompanied by a decrease of proSP-C, an ATII marker. Moreover, HOPX expression was increased in AECs from bleomycin-instilled mouse lungs in vivo. Small interfering RNA-based knockdown of Hopx resulted in suppressing ATII-ATI trans-differentiation and activating cellular proliferation in vitro. In IPF lungs, HOPX expression was decreased in whole lungs and significantly correlated to a decline in lung function and progression of IPF. In conclusion, HOPX is upregulated during early alveolar injury and repair process in the lung. Decreased HOPX expression might contribute to failed regenerative processes in end-stage IPF lungs.

Indexed as

Alveolar Epithelial CellsAnimalsBleomycinCell LineCell TransdifferentiationDisease Models, AnimalDisease ProgressionFemaleHomeodomain ProteinsHumansIdiopathic Pulmonary FibrosisIntercellular Signaling Peptides and ProteinsLungMiceMice, Inbred C57BLPulmonary AlveoliBleomycinHod protein, mouseHomeodomain ProteinsHOPX protein, humanIntercellular Signaling Peptides and ProteinsPulmonary Surfactant-Associated Protein CRNA, Small InterferingSftpc protein, mouseTumor Suppressor Proteins

Identifiers

PMID30154568
PMCPMC6113210
OpenAlexW2888230220

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.